UFM
CORZ icon

Ursa Fund Management’s Core Scientific CORZ Stock Holding History

Ursa Fund Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-30,000
Closed -$217K – 34
2025
Q1 		$217K Buy
+30,000
New +$341K 0.56% 17

Other funds holding CORZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
Gullane Capital Memphis, Tennessee $37.4M AUM 112.18% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OWP
ORG Wealth Partners Dallas, Texas $508M AUM 83.62% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Ursa Fund Management's CORZ Position: Q2 2025 in Review

Ursa Fund Management sold out of Core Scientific (CORZ) in Q2 2025, closing a stake of 30,000 shares — an estimated $217K sold.

Ursa Fund Management first reported a position in CORZ in Q1 2025 and held it in 1 quarter. The position peaked at $217K in Q1 2025. 370 funds tracked by Wall St. Rank hold CORZ as of Q2 2025.

  • Ursa Fund Management reported no remaining Core Scientific position as of Q2 2025 after selling out during the quarter.
  • Ursa Fund Management sold 30,000 Core Scientific shares in Q2 2025, an estimated $217K.
  • Ursa Fund Management first reported a position in Core Scientific in Q1 2025 and held it in 1 quarter.
  • Ursa Fund Management's Core Scientific position peaked at $217K in Q1 2025.
  • 370 funds tracked by Wall St. Rank held Core Scientific as of Q2 2025.

Based on Ursa Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.